Dr Morelli on the Ongoing Investigation of A2B530 in Advanced or Metastatic Solid Tumors
November 7th 2023Maria Pia Morelli, MD, PhD, discusses the ongoing investigation of A2B530, a Tmod™ CAR T-cell therapy, in advanced or metastatic solid tumors and highlights forward-facing research with the agent.
Read More